Atropine Bioequivalence

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Atropine Bioequivalence trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT06366087

Sublingual Atropine Bioequivalence by Route of Administration (SABER)

A randomized, two-period, two-sequence, crossover study to assess the bioequivalence, bioavailability, and pharmacokinetics (PK) of a single dose of atropine ad…

United States46 participantsStarted 2024-04-15

Treatment: Atropine Sulfate Ophthalmic Solution USP, 1%, Atropine Sulfate Injection, USP 8 mg/20 mL (0.4 mg/mL)